Moderna Data - Search News

Moderna, Senior FDA

Moderna says FDA refuses to review its application for experimental flu shot

The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said.

Opinion

· 20h

Moderna Has a Promising New Flu mRNA Vaccine. Trump’s FDA Wants Nothing to Do With It

· 8h · on MSN

FDA Refuses to Review Moderna’s New Flu Shot

· 1d

F.D.A. Refuses to Review Moderna Flu Vaccine

The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy...

· 1d

FDA officials defend decision to not review Moderna’s new flu vaccine

· 1d

FDA refuses Moderna’s mRNA flu vaccine application

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna

Seeking Alpha

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of ...

The National Law Review

Moderna Announces Data to be Presented at ESMO Congress 2025

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 European Society for Medical Oncology (ESMO ...